We are live on ! Find out more
JAGX icon

Jaguar Health
JAGX

8 hedge funds and large institutions have $15.9K invested in Jaguar Health in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

20% less funds holding

Funds holding: 10 → 8 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

83% less capital invested

Capital invested by funds: $94.2K → $15.9K (-$78.3K)

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$7.05K
2
UBS Group
UBS Group
Switzerland
+$4.99K
3
Barclays
Barclays
United Kingdom
+$361
4
SS
SBI Securities
Japan
+$71

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$40.8K
2
HF
HRT Financial
New York
-$5K
3
TSS
Two Sigma Securities
New York
-$4.65K
4
Wells Fargo
Wells Fargo
California
-$6
5
BlackRock
BlackRock
New York
-$1

JAGX Hedge Fund Activity: Q2 2026 in Review

8 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q2 2026, worth a combined $15.9K — down 83% from $94.2K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of JAGX and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $7.05K. The largest seller was Geode Capital Management, exiting entirely with an estimated $40.8K sold.

  • 8 institutional investors held Jaguar Health (JAGX) as of Q2 2026, down from 10 in Q1 2026.
  • Funds reported $15.9K of Jaguar Health stock for Q2 2026, down 83% quarter-over-quarter.
  • 1 fund opened new Jaguar Health positions in Q2 2026 and 3 closed out, a net change of -2 holders.
  • The largest Jaguar Health buyer in Q2 2026 was Tower Research Capital (TRC), an estimated $7.05K added.
  • The largest Jaguar Health seller in Q2 2026 was Geode Capital Management, an estimated $40.8K sold.

Based on aggregated 13F filings for Q2 2026.